Journal of Neurophysiology, Vol 72, Issue 5 2542-2546, Copyright © 1994 by APS

ARTICLES

Retinal ganglion neurons express a toxin-resistant developmentally regulated novel type of high-voltage-activated calcium channel

T. Rothe and R. Grantyn
Developmental Neurobiology, Max Planck Institute for Psychiatry, Martinsried, Germany.

1. High-voltage-activated Ca2+ currents [ICa(HVA)] were studied in immunolabeled mouse retinal ganglion neurons (RGNs) to elucidate channel-specific components and their developmental changes in vitro. 2. Neurons were dissociated at postnatal day 5. RGNs were selected for electrophysiological measurements by vital labeling with an antibody against Thy-1.2. ICa(HVA) were recorded with patch electrodes in the whole cell configuration at a holding voltage (Vh) of -90 mV. 3. A total of 111 neurons was studied. On average, 13% of ICa(HVA) was reversibly blocked by 10 microM nifedipine, approximately 30% of the compound current displayed an irreversible block by 2.5 microM omega-conotoxin (omega-CTX) GVIA. The remainder current was resistant to both drugs, suggesting that the total ICa(HVA) was a mixture of at least three different components. 4. Developmental analysis revealed a significant increase of the omega-CTX-GVIA/nifedipine-resistant component of ICa(HVA) (31% at day in vitro (DIV) 0-2, 70% at DIV 18-26) mainly at the expense of the omega-CTX-GVIA-sensitive current. No significant change was found in the nifedipine-sensitive component of ICa(HVA). 5. To characterize the Ca2+ current component that was resistant to both omega-CTX-GVIA and nifedipine at Vh -90 mV, three tests were performed. The P channel antagonist omega-agatoxin IVA (omega-Aga-IVA, 200 nM) completely failed to block ICa(HVA) in mouse RGNs. The novel Ca2+ channel blocker omega-CTX-MVIIC (5 microM) decreased the ICa(HVA) remaining after omega-CTX-GVIA treatment by only approximately 10%.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				D. C. Baptiste, A. T. E. Hartwick, C. A. B. Jollimore, W. H. Baldridge, B. C. Chauhan, F. Tremblay, and M. E. M. Kelly Comparison of the Neuroprotective Effects of Adrenoceptor Drugs in Retinal Cell Culture and Intact Retina Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2666 - 2676. [Abstract] [Full Text] [PDF]

				A. J. Olson, A. Picones, and J. I. Korenbrot Developmental Switch in Excitability, Ca2+ and K+ Currents of Retinal Ganglion Cells and Their Dendritic Structure J Neurophysiol, October 1, 2000; 84(4): 2063 - 2077. [Abstract] [Full Text] [PDF]

				S. Schmid and E. Guenther Voltage-Activated Calcium Currents in Rat Retinal Ganglion Cells In Situ: Changes during Prenatal and Postnatal Development J. Neurosci., May 1, 1999; 19(9): 3486 - 3494. [Abstract] [Full Text] [PDF]

				C. Zhang and J. T. Schmidt Adenosine A1 Receptors Mediate Retinotectal Presynaptic Inhibition: Uncoupling by C-Kinase and Role in LTP During Regeneration J Neurophysiol, February 1, 1998; 79(2): 501 - 510. [Abstract] [Full Text] [PDF]

				G.-Y. Wang, G.-M. Ratto, S. Bisti, and L. M. Chalupa Functional Development of Intrinsic Properties in Ganglion Cells of the Mammalian Retina J Neurophysiol, December 1, 1997; 78(6): 2895 - 2903. [Abstract] [Full Text] [PDF]

				M. G. White, M. A. Crumling, and S. D. Meriney Developmental Changes in Calcium Current Pharmacology and Somatostatin Inhibition in Chick Parasympathetic Neurons J. Neurosci., August 15, 1997; 17(16): 6302 - 6313. [Abstract] [Full Text] [PDF]

				P. J. Kammermeier and S. W. Jones High-Voltage-Activated Calcium Currents in Neurons Acutely Isolated From the Ventrobasal Nucleus of the Rat Thalamus J Neurophysiol, January 1, 1997; 77(1): 465 - 475. [Abstract] [Full Text] [PDF]